All In Biotech

Drug Trial Radar · NCT03512132

Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Apr 24, 2018

Primary completion

Oct 2027

Study completion Oct 2027

Sponsor

Lead sponsor
Centre Hospitalier Universitaire DijonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 30, 2018

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A number of arguments suggest that the deterioration in high density lipoproteins (HDL) functioning may worsen with the development of nephropathy during type 1 diabetes (T1D). The objective of this study will be to investigate to what extent nephropathy in T1D patients in the microalbuminuria and macroalbuminuria stages, compared to T1D patients without nephropathy, is associated with an alteration in HDL functionality and changes in HDL size and composition (lipids with detailed study of phosphates and sphingolipids, main lipoproteins, inflammatory markers).

Conditions

  • Type 1 Diabetes

Interventions

  • Blood samplesBiological

    5 EDTA tubes of 7ml and 1 dry tube of 7 ml taken on an empty stomach

  • Urine sampleBiological

    Urine sample on an empty stomach

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ability to induce cholesterol effluxTime frame: inclusion
  2. Nitric oxide synthesisTime frame: inclusion
  3. Anti-inflammatory effectTime frame: inclusion

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chu Dijon Bourogne

    Dijon, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.